← FDA Drug Approvals (Drugs@FDA)

VORICONAZOLE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SLATE RUN PHARMA · Approved 2018-11-30

Drug application

FDA Application #

ANDA211661

Application type

Abbreviated New Drug Application (Generic)

Brand name

VORICONAZOLE

Generic name

VORICONAZOLE

Active ingredients

VORICONAZOLE

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

SLATE RUN PHARMA

Manufacturer

Slate Run Pharmaceuticals

First approval

2018-11-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown